Cervarix suspensie voor injectie ( DrugBank: - )


3 diseases
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus1
50Dermatomyositis1
107Juvenile idiopathic arthritis1

49. Systemic lupus erythematosus


Clinical trials : 946 Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-008169-36-NL
(EUCTR)
17/02/200929/12/2008Immune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV studyImmune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV study Juvenile Idiopathic ArthritisSystemic lupus erythematosus childhood dermatomyositis
MedDRA version: 9.1;Level: LLT;Classification code 10042947;Term: Systemic lupus erythematosus synd
MedDRA version: 9.1;Classification code 10059176;Term: Juvenile idiopathic arthritis
MedDRA version: 9.1;Classification code 10008521;Term: Childhood dermatomyositis
Trade Name: Cervarix suspensie voor injectie
Product Name: not applicable
Product Code: not applicable
University Medical Center UtrechtNULLNot RecruitingFemale: yes
Male: no
Netherlands

50. Dermatomyositis


Clinical trials : 182 Drugs : 229 - (DrugBank : 88) / Drug target genes : 48 - Drug target pathways : 147
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-008169-36-NL
(EUCTR)
17/02/200929/12/2008Immune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV studyImmune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV study Juvenile Idiopathic ArthritisSystemic lupus erythematosus childhood dermatomyositis
MedDRA version: 9.1;Level: LLT;Classification code 10042947;Term: Systemic lupus erythematosus synd
MedDRA version: 9.1;Classification code 10059176;Term: Juvenile idiopathic arthritis
MedDRA version: 9.1;Classification code 10008521;Term: Childhood dermatomyositis
Trade Name: Cervarix suspensie voor injectie
Product Name: not applicable
Product Code: not applicable
University Medical Center UtrechtNULLNot RecruitingFemale: yes
Male: no
Netherlands

107. Juvenile idiopathic arthritis


Clinical trials : 441 Drugs : 282 - (DrugBank : 56) / Drug target genes : 52 - Drug target pathways : 142
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2008-008169-36-NL
(EUCTR)
17/02/200929/12/2008Immune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV studyImmune response after Human Papillomavirus vaccination in patients with auto-immune disease - HPV study Juvenile Idiopathic ArthritisSystemic lupus erythematosus childhood dermatomyositis
MedDRA version: 9.1;Level: LLT;Classification code 10042947;Term: Systemic lupus erythematosus synd
MedDRA version: 9.1;Classification code 10059176;Term: Juvenile idiopathic arthritis
MedDRA version: 9.1;Classification code 10008521;Term: Childhood dermatomyositis
Trade Name: Cervarix suspensie voor injectie
Product Name: not applicable
Product Code: not applicable
University Medical Center UtrechtNULLNot RecruitingFemale: yes
Male: no
Netherlands